Enhanced Ghrelin Levels and Hypothalamic Orexigenic AgRP and NPY Neuropeptide Expression in Models of Jejuno-Colonic Short Bowel Syndrome

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Gillard, Laura ^a   Billiauws, Lore ^a,b   Stan Iuga, Bogdan ^a   Ribeiro Parenti, Lara ^a,c   Jarry, Anne Charlotte ^a   Cavin, Jean Baptiste ^a   Cluzeaud, Françoise ^a   Mayeur, Camille ^d   Thomas, Muriel ^d   Freund, Jean Noël ^e   Lacorte, Jean Marc ^f,g,h   Le Gall, Maude ^a   Bado, André ^a   Joly, Francisca ^a,b   Le Beyec, Johanne ^a,g,h  

^a CENTRE DE RECHERCHE SUR L INFLAMMATION   (France)

^b BEAUJON HOSPITAL   (France)

^c BICHAT HOSPITAL   (France)

^d UNIVERSITÉ PARIS SACLAY   (France)

^e UNIVERSITÉ DE STRASBOURG   (France)

^f INSERM   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; KI 67 ANTIGEN; MESSENGER RNA; NEUROPEPTIDE Y; PEPTIDE YY; PROGLUCAGON;

ADULT; AGED; ANASTOMOSIS; ANIMAL; BLOOD; COLON; DISEASE MODEL; FEEDING BEHAVIOR; FEMALE; HUMAN; HYPERPHAGIA; HYPOTHALAMUS; INTESTINE MUCOSA; JEJUNUM; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RAT; REAL TIME POLYMERASE CHAIN REACTION; SHORT BOWEL SYNDROME; WISTAR RAT;

ADULT; AGED; AGOUTI-RELATED PROTEIN; ANASTOMOSIS, SURGICAL; ANIMALS; COLON; DISEASE MODELS, ANIMAL; FEEDING BEHAVIOR; FEMALE; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; GLUCAGON-LIKE PEPTIDE 2; HUMANS; HYPERPHAGIA; HYPOTHALAMUS; INTESTINAL MUCOSA; JEJUNUM; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEUROPEPTIDE Y; PEPTIDE YY; PROGLUCAGON; RATS; RATS, WISTAR; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SHORT BOWEL SYNDROME;

EID: 84975509551     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep28345     Document Type: Article

References (50)

1. Nordgaard, I., Hansen, B. S. & Mortensen, P. B. Importance of colonic support for energy absorption as small-bowel failure proceeds. Am. J. Clin. Nutr. 64, 222-231 (1996).
2. Crenn, P. et al. Net digestive absorption and adaptive hyperphagia in adult short bowel patients. Gut 53, 1279-1286 (2004).
3. Jeppesen, P. B. et al. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon. Gut 47, 370-376 (2000).
4. Nightingale, J. M. et al. Gastrointestinal hormones in short bowel syndrome. Peptide YY may be the 'colonic brake' to gastric emptying. Gut 39, 267-272 (1996).
5. Messing, B. et al. Intestinal absorption of free oral hyperalimentation in the very short bowel syndrome. Gastroenterology 100, 1502-1508 (1991).
6. Joly, F. et al. Drastic changes in fecal and mucosa-associated microbiota in adult patients with short bowel syndrome. Biochimie 92, 753-761 (2010).
7. Mayeur, C. et al. Faecal D/L lactate ratio is a metabolic signature of microbiota imbalance in patients with short bowel syndrome. PloS One 8, e54335 (2013).
8. Mayeur, C. et al. Extensive Intestinal Resection Triggers Behavioral Adaptation, Intestinal Remodeling and Microbiota Transition in Short Bowel Syndrome. Microorganisms 4, 16 (2016).
9. Kelberman, I., Cheetham, B. C., Rosenthal, J. & Levine, G. M. Effect of fiber and its fermentation on colonic adaptation after cecal resection in the rat. JPEN J. Parenter. Enteral Nutr. 19, 100-106 (1995).
10. Jeppesen, P. B. et al. Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 120, 806-815 (2001).
11. Koopmann, M. C. et al. Colonic GLP-2 is not sufficient to promote jejunal adaptation in a PN-dependent rat model of human short bowel syndrome. JPEN J. Parenter. Enteral Nutr. 33, 629-638-639 (2009).
12. Martin, G.-R., Beck, P.-L. & Sigalet, D.-L. Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation. World J. Gastroenterol. WJG 12, 4117-4129 (2006).
13. Jeppesen, P. B. et al. Impaired meal stimulated glucagon-like peptide 2 response in ileal resected short bowel patients with intestinal failure. Gut 45, 559-563 (1999).
14. Sobrino Crespo, C., Perianes Cachero, A., Puebla Jiménez, L., Barrios, V. & Arilla Ferreiro, E. Peptides and food intake. Front. Endocrinol. 5, 58 (2014).
15. Hsieh, J. et al. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36. Gastroenterology 137, 997-1005, 1005-4 (2009).
16. Cheeseman, C. I. Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo. Am. J. Physiol. 273, R1965-1971 (1997).
17. Baggio, L. L. & Drucker, D. J. Biology of incretins: GLP-1 and GIP. Gastroenterology 132, 2131-2157 (2007).
18. Drucker, D. J. & Yusta, B. Physiology and pharmacology of the enteroendocrine hormone glucagon-like peptide-2. Annu. Rev. Physiol. 76, 561-583 (2014).
19. Maljaars, P. W. J., Peters, H. P. F., Mela, D. J. & Masclee, A. A. M. Ileal brake: a sensible food target for appetite control. A review. Physiol. Behav. 95, 271-281 (2008).
20. Messing, B. et al. Long-term survival and parenteral nutrition dependence in adult patients with the short bowel syndrome. Gastroenterology 117, 1043-1050 (1999).
21. Cummings, D. E. et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 50, 1714-1719 (2001).
22. Cummings, D. E., Frayo, R. S., Marmonier, C., Aubert, R. & Chapelot, D. Plasma ghrelin levels and hunger scores in humans initiating meals voluntarily without time- and food-related cues. Am. J. Physiol. Endocrinol. Metab. 287, E297-304 (2004).
23. van der Klaauw, A. A. & Farooqi, I. S. The hunger genes: pathways to obesity. Cell 161, 119-132 (2015).
24. Chen, H. Y. et al. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 145, 2607-2612 (2004).
25. Compher, C. W., Kinosian, B. P. & Metz, D. C. Ghrelin does not predict adaptive hyperphagia in patients with short bowel syndrome. JPEN J. Parenter. Enteral Nutr. 33, 428-432 (2009).
26. Healey, K. L. et al. Morphological and functional changes in the colon after massive small bowel resection. J. Pediatr. Surg. 45, 1581-1590 (2010).
27. Ljungmann, K. et al. Time-dependent intestinal adaptation and GLP-2 alterations after small bowel resection in rats. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G779-785 (2001).
28. Martin, G. R. et al. Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome. Am. J. Physiol. Gastrointest. Liver Physiol. 288, G431-438 (2005).
29. Joly, F. et al. Morphological adaptation with preserved proliferation/transporter content in the colon of patients with short bowel syndrome. Am. J. Physiol. Gastrointest. Liver Physiol. 297, G116-123 (2009).
30. Neary, N. M., Druce, M. R., Small, C. J. & Bloom, S. R. Acylated ghrelin stimulates food intake in the fed and fasted states but desacylated ghrelin has no effect. Gut 55, 135 (2006).
31. Mason, B. L., Wang, Q. & Zigman, J. M. The central nervous system sites mediating the orexigenic actions of ghrelin. Annu. Rev. Physiol. 76, 519-533 (2014).
32. Müller, T. D. et al. Ghrelin. Mol. Metab. 4, 437-460 (2015).
33. Verhulst, P. J., Janssen, S., Tack, J. & Depoortere, I. Role of the AMP-activated protein kinase (AMPK) signaling pathway in the orexigenic effects of endogenous ghrelin. Regul. Pept. 173, 27-35 (2012).
34. Cowley, M. A. et al. The distribution and mechanism of action of ghrelin in the CNS demonstrates a novel hypothalamic circuit regulating energy homeostasis. Neuron 37, 649-661 (2003).
35. van der Klaauw, A. A. & Farooqi, I. S. The hunger genes: pathways to obesity. Cell 161, 119-132 (2015).
36. Molina, A. et al. Serum leptin concentrations in patients with short-bowel syndrome. Clin. Nutr. Edinb. Scotl. 19, 333-338 (2000).
37. Goldstein, J. L. et al. Surviving starvation: essential role of the ghrelin-growth hormone axis. Cold Spring Harb. Symp. Quant. Biol. 76, 121-127 (2011).
38. Fetissov, S. O. et al. Alterations of arcuate nucleus neuropeptidergic development in contactin-deficient mice: comparison with anorexia and food-deprived mice. Eur. J. Neurosci. 22, 3217-3228 (2005).
39. Wichmann, A. et al. Microbial modulation of energy availability in the colon regulates intestinal transit. Cell Host Microbe 14, 582-590 (2013).
40. Kunkel, D. et al. Efficacy of the glucagon-like peptide-1 agonist exenatide in the treatment of short bowel syndrome. Neurogastroenterol. Motil. Off. J. Eur. Gastrointest. Motil. Soc. 23, 739-e328 (2011).
41. Jeppesen, P. B. et al. Short bowel patients treated for two years with glucagon-like Peptide 2: effects on intestinal morphology and absorption, renal function, bone and body composition, and muscle function. Gastroenterol. Res. Pract. 2009, 616054 (2009).
42. Okuno, M. et al. Peptide YY enhances NaCl and water absorption in the rat colon in vivo. Experientia 48, 47-50 (1992).
43. Wewer Albrechtsen, N. J., Kuhre, R. E., Toräng, S. & Holst, J. J. The intestinal distribution pattern of appetite- and glucose regulatory peptides in mice, rats and pigs. BMC Res. Notes 9, 60 (2016).
44. Lardy, H. et al. Changes induced in colonocytes by extensive intestinal resection in rats. Dig. Dis. Sci. 51, 326-332 (2006).
45. Tolhurst, G. et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61, 364-371 (2012).
46. Zhou, J. et al. Dietary resistant starch upregulates total GLP-1 and PYY in a sustained day-long manner through fermentation in rodents. Am. J. Physiol. Endocrinol. Metab. 295, E1160-1166 (2008).
47. Delzenne, N. M., Cani, P. D., Daubioul, C. & Neyrinck, A. M. Impact of inulin and oligofructose on gastrointestinal peptides. Br. J. Nutr. 93 Suppl 1, S157-161 (2005).
48. Wu, T. et al. Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans. Diabetes Obes. Metab. 15, 474-477 (2013).
49. Onaga, T., Zabielski, R. & Kato, S. Multiple regulation of peptide YY secretion in the digestive tract. Peptides 23, 279-290 (2002).
50. Dossa, A. Y. et al. Bile acids regulate intestinal cell proliferation by modulating EGFR and FXR signaling. Am. J. Physiol. Gastrointest. Liver Physiol. 310, G81-92 (2016).